menu search

Pfizer gets FDA panel’s backing in RSV vaccine race

By Khushi Mandowara and Mariam ESunny (Reuters) – A panel of outside advisers to the U.S. health regulator on Tuesday recommended Pfizer Inc’s respiratory syncytial virus (RSV) vaccine, bringing it closer to becoming one of the first approved RSV shots for older adults in the The post Pfizer gets FDA panel’s backing in RSV vaccine race appeared first on ForexTV... Read More
Posted: Mar 1 2023, 00:06
Author Name: forextv
Views: 082246

Search within

Pages Search Results: